Heidi Greulich

USPTO Granted Patents = 12 (Patent Applications = 10)

CIPO Patents = 1 (Patent Applications = 9)

EPO Patents = 8 (Patent Applications = 12)

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

Boston, MA (US) (2021)
Cambridge, MA (US) (2021 - 2023)
Arlington, MA (US) (2018 - 2024)

Company Filing History:

12 out of 443

The Broad Institute, Inc.

patents

10 out of 1,206

Dana-farber-cancer Institute Inc.

patents

8 out of 378

Bayer Pharma Aktiengesellschaft

patents

4. 7 out of 12,157

Bayer Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12427153 - 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases (2025-09-30),

2. 12403135 - 4H-pyrrolo[3,2-c]pyridin-4-one derivatives (2025-09-02),

3. 12325880 - Identification of PDE3 modulator responsive cancers (2025-06-10),

4. 12258323 - Dihydrooxadiazinones (2025-03-25),

5. 12053476 - Compounds, compositions and methods for cancer patient stratification and cancer treatment (2024-08-06),

6. 11773070 - Dihydrooxadiazinones (2023-10-03),

7. 11427553 - Dihydrooxadiazinones (2022-08-30),

8. 11339157 - 4H-pyrrolo[3,2-c]pyridin-4-one derivatives (2022-05-24),

9. 11207320 - Compositions and methods for cancer expressing PDE3A or SLFN12 (2021-12-28),

10. 11142522 - Compounds, compositions and methods for cancer treatment (2021-10-12),

11. 10966986 - Compounds, compositions and methods for cancer patient stratification and cancer treatment (2021-04-06),

12. 9890127 - Compounds and compositions for the treatment of cancer (2018-02-13),

Title: The Innovative Contributions of Heidi Greulich

Introduction

Heidi Greulich is a prominent inventor based in Cambridge, MA, known for her significant contributions to the field of pharmaceuticals. With a total of 12 patents to her name, she has made remarkable strides in developing compounds for the treatment of hyperproliferative diseases.

Latest Patents

Among her latest patents, one notable invention includes 1,2,4-triazin-3(2H)-one compounds aimed at treating hyperproliferative diseases. This invention encompasses compounds of general formula (I), where R, R, R, and R are defined within the patent. Additionally, she has developed 4H-pyrrolo[3,2-c]pyridin-4-one derivatives, which are designed for the treatment or prophylaxis of diseases responsive to cell death induction, particularly targeting hematological tumors and solid tumors harboring mutant EGFR with exon 19 or 21 mutations.

Career Highlights

Heidi has worked with esteemed organizations such as the Broad Institute, Inc. and Dana-Farber Cancer Institute Inc. Her work in these institutions has been pivotal in advancing cancer research and treatment methodologies.

Collaborations

Heidi has collaborated with notable professionals in her field, including Matthew Meyerson and Xiaoyun Wu. These partnerships have further enhanced her research and innovation capabilities.

Conclusion

Heidi Greulich's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her as a leading figure in the fight against hyperproliferative diseases. Her work continues to inspire advancements in medical research and treatment options.

This text is generated by artificial intelligence and may not be accurate.